Is Evolent Health Inc (EVH) overvalued? · rev $646.5M
Evolent Health Inc (EVH) is a health information services company listed on US.
This page asks whether Evolent Health Inc (EVH) looks expensive on cached numbers — not a short thesis.
Latest reported EVH revenue for 2024-12-31 was $646.5M. Net income was -$22.8M. Revenue was up 4.0% from 2024-09-30 to 2024-12-31. EVH currently screens at market cap $474.7M.
EVH currently screens at market cap $474.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next EVH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the EVH stock page for the full model, not this heading.
Not investment advice.